Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mobilization with etoposide and granulocyte colony-stimulating factor can replace bone marrow harvesting in patients with malignant lymphoma who previously failed to mobilize sufficient stem cells with cyclophosphamide and G-CSF.
Scheid C, Reiser M, Draube A, Josting A, Fuchs M, Chemnitz J, Winter S, Schultz A, Engert A, Diehl V, Söhngen D. Scheid C, et al. Among authors: reiser m. J Hematother Stem Cell Res. 2000 Aug;9(4):411-3. doi: 10.1089/152581600419053. J Hematother Stem Cell Res. 2000. PMID: 10982237 No abstract available.
Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue--a highly effective regimen for patients with refractory or relapsed indolent lymphoma.
Josting A, Reiser M, Wickramanayake PD, Rueffer U, Draube A, Söhngen D, Tesch H, Wolf J, Diehl V, Engert A. Josting A, et al. Among authors: reiser m. Leuk Lymphoma. 2000 Mar;37(1-2):115-23. doi: 10.3109/10428190009057634. Leuk Lymphoma. 2000. PMID: 10721775 Clinical Trial.
Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study.
Rödel S, Engert A, Diehl V, Reiser M. Rödel S, et al. Among authors: reiser m. Leuk Lymphoma. 2005 Dec;46(12):1729-34. doi: 10.1080/10428190500215225. Leuk Lymphoma. 2005. PMID: 16353313 Clinical Trial.
2,341 results